OmniAb (OABI) Share-based Compensation (2022 - 2026)

OmniAb's (OABI) quarterly Share-based Compensation came in at $3.3 million in Q1 2026, down 19.4% year-on-year from $4.1 million in Q1 2025, and down 78.89% on a QoQ basis from $15.8 million in Q4 2025.

OmniAb (OABI) Share-based Compensation (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Share-based Compensation data on file, last reported at $3.3 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation fell 19.4% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $15.0 million, a 1093.39% increase from a year earlier, with the FY2025 full-year figure at $15.8 million, up 40474.36% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $3.3 million, down from $15.8 million in the prior quarter.
  • Over the last five years, Share-based Compensation for OABI reached as high as $15.8 million in Q4 2025 and fell as low as -$10.1 million in Q3 2024.
  • Historically, Share-based Compensation has averaged $1.9 million across 5 years, with a median of $3.2 million in 2022.
  • Across the five-year window, Share-based Compensation slumped 56311.11% in 2024 and jumped 1818.13% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $10.1 million in 2022, then sank by 95.96% to $410000.0 in 2023, then plunged by 324.63% to -$921000.0 in 2024, then soared by 1818.13% to $15.8 million in 2025, then tumbled by 78.89% to $3.3 million in 2026.
  • Per Business Quant data, the three most recent Share-based Compensation figures were $3.3 million in Q1 2026, $15.8 million in Q4 2025, and -$8.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 OmniAb 261.62 Mn 212.55 Mn 14.41 Mn 3.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.34 Mn
Mar 31, 2026 3.34 Mn
Dec 31, 2025 15.82 Mn
Dec 31, 2025 15.82 Mn
Sep 30, 2025 -8.26 Mn
Sep 30, 2025 -8.26 Mn
Jun 30, 2025 4.11 Mn
Jun 30, 2025 4.11 Mn
Mar 31, 2025 4.14 Mn
Mar 31, 2025 4.14 Mn
Dec 31, 2024 -921,000.00
Dec 31, 2024 -921,000.00
Sep 30, 2024 -10.12 Mn
Sep 30, 2024 -10.12 Mn
Jun 30, 2024 5.38 Mn
Jun 30, 2024 5.38 Mn
Mar 31, 2024 5.70 Mn
Mar 31, 2024 5.70 Mn
Dec 31, 2023 410,000.00
Dec 31, 2023 410,000.00